Denmark First EU Country to Authorise Anti-COVID Pill Amid Record Spread

Despite disappointing trial results, which reduced the rate of hospitalisation and death for at-risk patients by 30 percent instead of the 50 percent promised before, the Danish health authorities remains convinced that the benefits of the molnupiravir pill outweigh the risks, especially as the country continues to break infection records.